We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$378M
AUM Growth
-$71.4M
Cap. Flow
-$107M
Cap. Flow %
-28.29%
Top 10 Hldgs %
64.24%
Holding
31
New
1
Increased
8
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$3.32M
2
CAH icon
Cardinal Health
CAH
+$2.85M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$2.28M
4
MDCO
Medicines Co
MDCO
+$1.78M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.61M

Top Sells

Rank Stock Value
1
HSP
HOSPIRA INC
HSP
+$17.4M
2
VTRS icon
Viatris
VTRS
+$14.5M
3
PDCO
Patterson Companies, Inc.
PDCO
+$11.4M
4
BSX icon
Boston Scientific
BSX
+$9.09M
5
DGX icon
Quest Diagnostics
DGX
+$8.59M

Sector Composition

Rank Sector Weight
1 Healthcare 89.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAX icon
1
Baxter International
BAX
$11.7B
$43.9M 11.62%
1,181,002
+87,632
+8% +$3.32M
BSX icon
2
Boston Scientific
BSX
$65.4B
$37.6M 9.94%
2,117,600
-575,000
-21% -$9.09M
LLY icon
3
Eli Lilly
LLY
$1.05T
$33.9M 8.96%
466,447
-82,000
-15% -$5.84M
SYK icon
4
Stryker
SYK
$123B
$23M 6.07%
248,883
-800
-0.3% -$74.5K
RVTY icon
5
Revvity
RVTY
$12.3B
$21.5M 5.68%
420,260
-9,500
-2% -$440K
IRWD icon
6
Ironwood Pharmaceuticals
IRWD
$635M
$18.6M 4.92%
1,387,656
+20,298
+1% +$266K
CAH icon
7
Cardinal Health
CAH
$53.5B
$18M 4.77%
199,800
+33,100
+20% +$2.85M
BMY icon
8
Bristol-Myers Squibb
BMY
$124B
$17.8M 4.7%
275,900
-109,300
-28% -$6.84M
EW icon
9
Edwards Lifesciences
EW
$49.4B
$15.7M 4.16%
663,000
-304,200
-31% -$6.82M
THC icon
10
Tenet Healthcare
THC
$16.8B
$12.9M 3.42%
261,500
+4,000
+2% +$187K
BIO icon
11
Bio-Rad Laboratories Class A
BIO
$8.15B
$12.5M 3.3%
92,400
-3,800
-4% -$471K
CI icon
12
Cigna
CI
$74.5B
$12.3M 3.26%
95,200
+1,200
+1% +$139K
WCG
13
DELISTED
Wellcare Health Plans, Inc.
WCG
$11.9M 3.16%
130,545
-4,200
-3% -$351K
TEVA icon
14
Teva Pharmaceuticals
TEVA
$37.3B
$11.5M 3.03%
184,000
+27,700
+18% +$1.61M
IART icon
15
Integra LifeSciences
IART
$1.5B
$11.4M 3.01%
452,507
+53,333
+13% +$1.26M
THOR
16
DELISTED
THORATEC CORPORATION
THOR
$10.5M 2.76%
249,500
-143,000
-36% -$5.46M
MDCO
17
DELISTED
Medicines Co
MDCO
$9.15M 2.42%
326,650
+63,200
+24% +$1.78M
DGX icon
18
Quest Diagnostics
DGX
$23.3B
$8.81M 2.33%
114,628
-120,000
-51% -$8.59M
LPNT
19
DELISTED
LifePoint Health, Inc.
LPNT
$8.79M 2.32%
119,698
-103,202
-46% -$7.32M
VRTX icon
20
Vertex Pharmaceuticals
VRTX
$123B
$8.78M 2.32%
74,463
-28,000
-27% -$3.35M
MASI
21
DELISTED
Masimo
MASI
$8.72M 2.31%
264,423
-17,000
-6% -$489K
RAD
22
DELISTED
Rite Aid Corporation
RAD
$6.74M 1.78%
38,800
-19,250
-33% -$3M
CYH icon
23
Community Health Systems
CYH
$465M
$5.95M 1.57%
137,698
-22,143
-14% -$917K
COR icon
24
Cencora
COR
$59.9B
$5.15M 1.36%
45,300
-67,200
-60% -$6.76M
MNTA
25
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.66M 0.7%
+175,100
New +$2.28M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2015 Portfolio in Review

As of Q1 2015, Sector Gamma AS held 31 positions worth $378M, down 16% from $450M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Sector Gamma AS withdrew a net $107M in Q1 2015, closing 5 positions and reducing 16 holdings. Its most notable exit was HOSPIRA INC, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 91% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Momenta Pharmaceuticals, Inc. worth $2.66M.

  • Sector Gamma AS's largest Q1 2015 buy was Momenta Pharmaceuticals, Inc.: 175,100 shares worth $2.66M.
  • Sector Gamma AS added most to Baxter International in Q1 2015, an estimated $3.32M increase.
  • Sector Gamma AS's biggest Q1 2015 reduction was Boston Scientific, cutting an estimated $9.09M.
  • Sector Gamma AS fully exited HOSPIRA INC in Q1 2015, selling an estimated $17.4M.
  • Sector Gamma AS's ten largest holdings make up 64% of its $378M portfolio in Q1 2015.
  • Sector Gamma AS opened 1 new position and closed 5 in Q1 2015.
  • Sector Gamma AS's portfolio value fell 16% quarter-over-quarter to $378M.

Based on Sector Gamma AS's 13F filing for Q1 2015, filed 14 May 2015.